Quantitative and Site-Specific Profiling of Protein O-GlcNAcylation in Carboplatin-Treated Cancer Cells
Journal of Proteome Research · 07.08.2026 · 25 (8) · 4351-4359
DOI: 10.1021/acs.jproteome.6c00333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 23.06.2026. Verfasst von Qingsong Xie und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Glycoengineering Research Center, Shandong University, Qingdao266237, Shandong, China. Hauptthemen laut MEDLINE: Carboplatin, Acetylglucosamine, Antineoplastic Agents, Protein Processing, Post-Translational. Die Arbeit nennt 64 Literaturangaben. Gefördert von: Shandong University, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Platinum (Pt)-based chemotherapeutics are widely used for cancer treatment in clinical trials. It has been reported that protein O-linked β-N-acetylglucosamine (O-GlcNAc) modification occurs on several important proteins implicated in regulating cancer cell response to Pt drugs. However, the O-GlcNAc proteomic landscape during this process remains poorly characterized. Herein, we report quantitative profiling of O-GlcNAcylation sites with carboplatin exposure, by using a chemoenzymatic labeling-assisted chemoproteomic approach. A total of 244 O-GlcNAcylated sites, many of which occur on essential genome stability regulators, are quantified. Furthermore, we discover that the cellular O-GlcNAc level is elevated upon carboplatin treatment and suppression of O-GlcNAcylation renders cancer cells more sensitive to carboplatin. These results establish a valuable resource for elucidating the functional role of O-GlcNAcylation in carboplatin response and suggest potential insights into cancer chemotherapy. The chemoproteomic strategy should be generally applicable for monitoring O-GlcNAc dynamic changes in various pharmacological processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Glycoengineering Research Center, Shandong University, Qingdao266237, Shandong, China.
- Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, College of Health Science and Engineering, Hubei University, Wuhan430062, Hubei, China.
Förderung
- Shandong University
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Natural Science Foundation of Shandong Province
- Taishan Scholar Foundation of Shandong Province
Zitieren
APA
Xie, Q., Zhang, C., Chen, G., Li, X., & Hao, Y. (2026). Quantitative and Site-Specific Profiling of Protein O-GlcNAcylation in Carboplatin-Treated Cancer Cells. Journal of Proteome Research, 25(8), 4351-4359. https://doi.org/10.1021/acs.jproteome.6c00333
Vancouver
Xie Q, Zhang C, Chen G, Li X, Hao Y. Quantitative and Site-Specific Profiling of Protein O-GlcNAcylation in Carboplatin-Treated Cancer Cells. Journal of Proteome Research. 2026;25(8):4351-4359. doi:10.1021/acs.jproteome.6c00333
BibTeX
@article{Xie2026,
author = {Xie, Qingsong and Zhang, Cheng and Chen, Gang and Li, Xiang and Hao, Yi},
title = {Quantitative and Site-Specific Profiling of Protein O-GlcNAcylation in Carboplatin-Treated Cancer Cells},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {8},
pages = {4351--4359},
doi = {10.1021/acs.jproteome.6c00333}
}
EUVIMED